tradingkey.logo

BUZZ-Apellis rises after quarterly revenue beats estimates

ReutersFeb 28, 2025 12:40 PM

Shares of Apellis Pharmaceuticals APLS.O rise 7.7% to $28.01 premarket, set to snap six-day losing streak

Drugmaker's Q4 revenue of $212.5 mln beats Wall Street estimates of $198.4 mln - LSEG

Q4 net loss $36.4 mln, narrower than $88.6 mln a year ago

APLS fell 46.7% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI